rdf:type |
|
lifeskim:mentions |
umls-concept:C0014822,
umls-concept:C0017262,
umls-concept:C0030705,
umls-concept:C0038952,
umls-concept:C0059570,
umls-concept:C0185117,
umls-concept:C0220901,
umls-concept:C0441767,
umls-concept:C0597360,
umls-concept:C0684249,
umls-concept:C1517600,
umls-concept:C2587213,
umls-concept:C2911684
|
pubmed:issue |
2
|
pubmed:dateCreated |
2011-5-9
|
pubmed:abstractText |
Prognostic factors can guide the physician in selecting the optimal treatment for an individual patient. This study investigates the prognostic value of erythropoietin (EPO) and EPO receptor (EPO-R) expression of tumor cells for locoregional control and survival in non-small-cell lung cancer (NSCLC) patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1879-355X
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
80
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
499-505
|
pubmed:meshHeading |
pubmed-meshheading:20646855-Age Factors,
pubmed-meshheading:20646855-Aged,
pubmed-meshheading:20646855-Analysis of Variance,
pubmed-meshheading:20646855-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:20646855-Erythropoietin,
pubmed-meshheading:20646855-Female,
pubmed-meshheading:20646855-Hemoglobin A,
pubmed-meshheading:20646855-Humans,
pubmed-meshheading:20646855-Karnofsky Performance Status,
pubmed-meshheading:20646855-Lung Neoplasms,
pubmed-meshheading:20646855-Male,
pubmed-meshheading:20646855-Middle Aged,
pubmed-meshheading:20646855-Neoplasm Proteins,
pubmed-meshheading:20646855-Neoplasm Staging,
pubmed-meshheading:20646855-Prognosis,
pubmed-meshheading:20646855-Radiotherapy, Conformal,
pubmed-meshheading:20646855-Receptors, Erythropoietin,
pubmed-meshheading:20646855-Sex Factors,
pubmed-meshheading:20646855-Smoking
|
pubmed:year |
2011
|
pubmed:articleTitle |
Prognostic impact of erythropoietin expression and erythropoietin receptor expression on locoregional control and survival of patients irradiated for stage II/III non-small-cell lung cancer.
|
pubmed:affiliation |
Department of Radiation Oncology, University of Lubeck, Germany. Rades.Dirk@gmx.net
|
pubmed:publicationType |
Journal Article
|